Publications
Patents & Papers
Our patent portfolio and key academic publications protecting and advancing RudaCure's core technology and research achievements.
10
Patent Families
35
Total Filings
4
Granted
11
Countries
7
Total Papers
Patent Portfolio
Securing global intellectual property rights for core ion channel drug discovery technologies.
Pharmaceutical Composition Containing 8-oxo-2'-deoxyguanosine for Treating Corneal Disease
Inventors: 정명희, 김동현
Eye Drop Formulations in Aqueous Solution Comprising 8-oxo-2'-deoxyguanosine
Inventors: 김동현, 박설규, 이동진, 김선경
2'-Deoxyguanosine Derivatives or Salts Thereof and Pharmaceutical Compositions
Inventors: 김용호, 김승훈, 구영아, 김완훈
Pharmaceutical Composition for Treating TRPV1-Mediated Diseases (GDF11 Active Ingredient)
Inventors: 김용호, 김승훈, 전하원, 하유승
A Novel Peptide and the Use Thereof
Inventors: 김용호, 김승훈, 전하원, 장예원
Composition for Pain Treatment
Inventors: 김승훈, 김윤연, 김재승, 최승혁
8-oxo-2'-Deoxyguanosine Derivatives
Inventors: 김용호, 김승훈, 강혜린, 조하늘, 용혜임, 김완훈
Pharmaceutical Composition for Prevention or Treatment of Pruritus Comprising TRPV1 Antagonist
Inventors: 김승훈, 신지윤, 김윤연, 용혜임, 구연수
Pharmaceutical Composition for Prevention or Treatment of Dry Eye Disease Comprising TRPV1 Antagonist
Inventors: 김승훈, 신지윤, 김윤연, 구영아, 최가은
Hypothalamus-Pituitary Biochip and Manufacturing Method Thereof
Inventors: -
Key Research Papers
RudaCure's key research achievements published in domestic and international SCI-indexed journals.
Efficacy of RCI001 as a Therapeutic Candidate in Ocular Surface Diseases
Kim SH et al.
Comparison of Corneal Epithelial Wound Healing between Topical RCI001, Solcoseryl, and Polydeoxyribonucleotide in the Murine Ocular Alkali Burn Model
Kim SH et al.
Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight Into the Mechanism of Action
Kim SH et al.
Comparison of Therapeutic Effects between Topical 8-oxo-2'-deoxyguanosine and Corticosteroid in Ocular Alkali Burn Model
Kim SH et al.
Ocular Distribution and Pharmacokinetics of 8-Oxo-2'-Deoxyguanosine: A Novel Therapeutic Candidate of Ocular Surface Diseases
Kim SH et al.
Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
Kim SH et al.
Improved Accuracy of Intraocular Lens Power Calculation by Preoperative Management of Dry Eye Disease
Kim SH et al.